SOTI and TROPOS phase III studies open-label extension. The long term efficacy and long term safety assessment of a five-year oral administration of strontium ranelate in osteoporotic postmenopausal women having participated either in Spinal Osteoporosis Therapeutic Intervention 'SOTI' study or TReatment Of Peripheral OSteoporosis 'TROPOS' study. A five-year multicentric multinational open study with strontium ranelate
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Strontium ranelate (Primary)
- Indications Fracture; Postmenopausal osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms SOTI; TROPOS
- Sponsors IRIS
Most Recent Events
- 09 Jun 2008 New trial record.